138 related articles for article (PubMed ID: 35518363)
1. Whether Screening for Non-alcoholic Fatty Liver Disease in Patients With Psoriasis Is Necessary: A Pilot Quality Improvement Project.
Torbator K; Poo S; Al-Rubaye T; Mapara L; Punjabi S; Al-Rubaye A; Alrubaiy L
Cureus; 2022 May; 14(5):e24714. PubMed ID: 35518363
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Chronic Plaque Psoriasis and Nonalcoholic Fatty Liver Disease in Indian Patients: Results of a Pilot Study.
Mahajan VK; Chauhan NS; Rana BS; Mehta KS; Hooda S; Chauhan PS; Kukreja A
J Clin Exp Hepatol; 2022; 12(3):785-792. PubMed ID: 35677516
[TBL] [Abstract][Full Text] [Related]
4. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
[TBL] [Abstract][Full Text] [Related]
5. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis.
Sagara M; Iijima T; Kase M; Kato K; Sakurai S; Tomaru T; Jojima T; Usui I; Aso Y
J Diabetes Complications; 2021 May; 35(5):107885. PubMed ID: 33602617
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach.
Perez-Carreras M; Casis-Herce B; Rivera R; Fernandez I; Martinez-Montiel P; Villena V
World J Gastroenterol; 2021 Nov; 27(41):7113-7124. PubMed ID: 34887631
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network?
Heitmann J; Frings VG; Geier A; Goebeler M; Kerstan A
J Dtsch Dermatol Ges; 2021 Apr; 19(4):517-528. PubMed ID: 33768700
[TBL] [Abstract][Full Text] [Related]
11. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
Lai LL; Wan Yusoff WNI; Vethakkan SR; Nik Mustapha NR; Mahadeva S; Chan WK
J Gastroenterol Hepatol; 2019 Aug; 34(8):1396-1403. PubMed ID: 30551263
[TBL] [Abstract][Full Text] [Related]
12. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.
Arora A; Sharma P
J Clin Exp Hepatol; 2012 Jun; 2(2):145-55. PubMed ID: 25755423
[TBL] [Abstract][Full Text] [Related]
14. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes.
Mantovani A; Turino T; Lando MG; Gjini K; Byrne CD; Zusi C; Ravaioli F; Colecchia A; Maffeis C; Salvagno G; Lippi G; Bonora E; Targher G
Diabetes Metab; 2020 Sep; 46(4):296-303. PubMed ID: 31786361
[TBL] [Abstract][Full Text] [Related]
15. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.
Campanati A; Ganzetti G; Di Sario A; Damiani A; Sandroni L; Rosa L; Benedetti A; Offidani A
J Gastroenterol; 2013 Jul; 48(7):839-46. PubMed ID: 23065020
[TBL] [Abstract][Full Text] [Related]
16. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of non-alcoholic fatty liver and liver fibrosis in patients with moderate-severe psoriasis: A cross-sectional cohort study.
Magdaleno-Tapial J; Valenzuela-Oñate C; Ortiz-Salvador JM; Martínez-Doménech Á; García-Legaz-Martínez M; Alonso-Carpio M; Tamarit-García JJ; Diago-Madrid M; Sánchez-Carazo JL; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):105-109. PubMed ID: 31731325
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
Behairy MA; Sherief AF; Hussein HA
Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
[TBL] [Abstract][Full Text] [Related]
19. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.
Conti F; Vukotic R; Foschi FG; Domenicali M; Giacomoni P; Savini S; Lanzi A; Dall'Aglio AC; Saini G; Matroroberto M; Bernardi M; Stefanini GF; Andreone P
Dig Liver Dis; 2016 Nov; 48(11):1357-1363. PubMed ID: 27522549
[TBL] [Abstract][Full Text] [Related]
20. Assessment of 10-year changes in liver stiffness using vibration-controlled transient elastography in non-alcoholic fatty liver disease.
Nogami A; Yoneda M; Kobayashi T; Kessoku T; Honda Y; Ogawa Y; Suzuki K; Tomeno W; Imajo K; Kirikoshi H; Koide T; Fujikawa H; Saito S; Nakajima A
Hepatol Res; 2019 Aug; 49(8):872-880. PubMed ID: 30974498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
